Pyxis Tankers Inc. (NASDAQ:PXS), Aileron Therapeutics, Inc. (NASDAQ:ALRN)

Pyxis Tankers Inc. (NASDAQ:PXS):

Last Trade:

Pyxis Tankers Inc. (NASDAQ:PXS) ended its previous trading session at $1.09 with the declined of -0.73%. The company’s market cap is $21.94 Million, and the average volume is $1.09 Million. The 52-Week High range of the stock is $3.7, while the 52-week low range is $0.64. The Price to Sales (P/S) of the stock is 0.78, while P/B (Price to Book) stands at 0.53. When we look at the Volatility of the company, Week Volatility is at 8.63% whereas Month Volatility is at 14.17%.


For the ongoing Fiscal Quarter, 2 analysts have an average earnings forecast of $-0.05 per share. According to the Analysts, the Low Earnings estimate for the current quarter is $-0.07, while the High earnings estimate is $-0.04.Comparatively, EPS for the same quarter last year was $0.04.


According to 2 analysts, the Average Revenue Estimate for the current Fiscal quarter is $5.88 Million and the Low Revenue estimate is $5.67 Million, while the High Revenue estimate is $6.1 Million.


Pyxis Tankers Inc. (NASDAQ:PXS) analysts on average have given a price target of $2.5 on PXS stock.


According to the Recommendation Trends of the stock polled by Zacks Investment Research for this month, the company has a consensus recommendation of 0 out of the scale from 1 to 5 where 1 stands for Strong Buy and 5 means Strong Sell.


Aileron Therapeutics, Inc. (NASDAQ:ALRN):


Previous Trade:

Aileron Therapeutics, Inc. (NASDAQ:ALRN) shares declined -2.65% and ended the day at $1.1. Its 52-week high and low range is between $9.76 and $0.52. The company’s outstanding shares are 14.34 Million. The volume of the company in the last trading session was 28469. The stock has a market cap of 15.77 Million. The Stock shows P/E value of 0 and Forward P/E of 0.


According to Finviz reported data, The SMA20 of the stock is at 0.54%, SMA50 is -25.22 percent, while SMA200 is -67.28%. The stock is currently has its Return on Assets (ROA) value of -70 Percent. The Return on Investment and Return on Equity (ROE) values are 0 percent and -85 percent, respectively.


The company’s ATR (Average True Range) is 0.19. The Weekly Volatility is 12.55% and the Monthly Volatility is 17.91%.


When we look at the Analyst Recommendations of the stock, the company has 1 rating given by Analysts where 1 stands for Strong Buy and 5 stands for Strong Sell.


Aileron Therapeutics, Inc. (NASDAQ:ALRN) analysts on average have given a price target of $2.5 on ALRN stock.


Aileron Therapeutics, Inc.’s Average Earnings Estimate for the current quarter is $-0.51, according to consensus of 1 analysts. The low EPS estimate is $-0.51, while the high EPS estimate is $-0.51.


Average Revenue Estimate of the company for the current Fiscal Quarter is $0, according to consensus of 1 analysts. The higher end of the revenue estimate is $0 and the lower end is $0.

SHARE

LEAVE A REPLY